Form 4: Maze Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Atul Dandekar, CSBO of Maze Therapeutics, Inc., sold 6,434 shares of common stock on September 2, 2026.
Summary
- Open-market sale: disposed of 2,800 Common Stock at $26.38 ($73,853) on September 2, 2026; holds 35,950 after (Direct).
- Open-market sale: disposed of 391 Common Stock at $27.12 ($10,604) on September 2, 2026; holds 35,559 after (Direct).
- Open-market sale: disposed of 3,207 Common Stock at $26.01 ($83,425) on September 3, 2026; holds 32,352 after (Direct).
- Open-market sale: disposed of 36 Common Stock at $25.81 ($929) on September 3, 2026; holds 32,316 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $168,811 of stock on the open market.
Insider Transactions
Atul Dandekar — Officer (CSBO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Open-market sale | Common Stock | 2,800 | $26 | $73.9K | 35,950 |
| 2026-09-02 | Open-market sale | Common Stock | 391 | $27 | $10.6K | 35,559 |
| 2026-09-03 | Open-market sale | Common Stock | 3,207 | $26 | $83.4K | 32,352 |
| 2026-09-03 | Open-market sale | Common Stock | 36 | $26 | $929 | 32,316 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Open-market sale (2,800 shares) |
| 2026-09-02 | Open-market sale (391 shares) |
| 2026-09-03 | Open-market sale (3,207 shares) |
| 2026-09-03 | Open-market sale (36 shares) |
Keywords
insider transaction, Form 4, MAZE, Maze Therapeutics, Inc., bearish, Atul Dandekar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.